AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Russell J. Schilder, MD
Fox Chase Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Saint Joseph Medical Center - Burbank
Burbank, California, United States
- George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
New Britain, Connecticut, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Illinois Cancer Center
Chicago, Illinois, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- St. Vincent Indianapolis Hospital
Indianapolis, Indiana, United States
- Hulston Cancer Center at Cox Medical Center South
Springfield, Missouri, United States
- St. John'S Regional Health Center
Springfield, Missouri, United States
- Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees Township, New Jersey, United States
- Blumenthal Cancer Center at Carolinas Medical Center
Charlotte, North Carolina, United States
- Case Comprehensive Cancer Center
Cleveland, Ohio, United States
- Mount Carmel Health - West Hospital
Columbus, Ohio, United States
- Lake/university Ireland Cancer Center
Mentor, Ohio, United States
- Oklahoma University Cancer Institute
Oklahoma City, Oklahoma, United States
- Rosenfeld Cancer Center at Abington Memorial Hospital
Abington, Pennsylvania, United States
- Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, United States
- Mcglinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania, United States
- Harrington Cancer Center
Amarillo, Texas, United States
- University of Virginia Cancer Center
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2007
- Primary completion
- 31 Jul 2013
- Completion
- —
- Last update posted
- 11 Jan 2018
- Registered enrollment
- 23
- Registry id
- NCT00574951
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.